154 related articles for article (PubMed ID: 37111767)
1. Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent.
Guimarães CJ; Carneiro TR; Frederico MJS; de Carvalho GGC; Little M; Freire VN; França VLB; do Amaral DN; Guedes JS; Barreiro EJ; Lima LM; Barros-Nepomuceno FWA; Pessoa C
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111767
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs.
Barbosa G; Gelves LGV; Costa CMX; Franco LS; Lima JAL; Aparecida-Silva C; Teixeira JD; Mermelstein CDS; Barreiro EJ; Lima LM
Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893736
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile.
Pillpe-Meza RM; Gouveia WL; Barbosa G; Fraga CAM; Barreiro EJ; Lima LM
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543175
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions.
Kardile RA; Sarkate AP; Lokwani DK; Tiwari SV; Azad R; Thopate SR
Eur J Med Chem; 2023 Jan; 245(Pt 1):114889. PubMed ID: 36375337
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition.
Amin MM; Abuo-Rahma GEA; Shaykoon MSA; Marzouk AA; Abourehab MAS; Saraya RE; Badr M; Sayed AM; Beshr EAM
Bioorg Chem; 2023 May; 134():106444. PubMed ID: 36893547
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling study, synthesis and biological evaluation of combretastatin A-4 analogues as anticancer agents and tubulin inhibitors.
Quan YP; Cheng LP; Wang TC; Pang W; Wu FH; Huang JW
Medchemcomm; 2018 Feb; 9(2):316-327. PubMed ID: 30108925
[TBL] [Abstract][Full Text] [Related]
10. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
13. Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors.
Kumar S; Mehndiratta S; Nepali K; Gupta MK; Koul S; Sharma PR; Saxena AK; Dhar KL
Org Med Chem Lett; 2013 Mar; 3(1):3. PubMed ID: 23452433
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity.
de Queiroz AC; Barbosa G; de Oliveira VRT; de Mattos Alves H; Alves MA; Carregaro V; Santana da Silva J; Barreiro EJ; Alexandre-Moreira MS; Lima LM
PLoS One; 2022; 17(6):e0269447. PubMed ID: 35666748
[TBL] [Abstract][Full Text] [Related]
15. Dual-functional antitumor conjugates improving the anti-metastasis effect of combretastatin A4 by targeting tubulin polymerization and matrix metalloproteinases.
Yang L; Ma X; Guo K; Li J; Zhang C; Wu L
Eur J Med Chem; 2022 Aug; 238():114439. PubMed ID: 35551039
[TBL] [Abstract][Full Text] [Related]
16. New Anticancer Theobromine Derivative Targeting EGFR
Elkaeed EB; Yousef RG; Elkady H; Alsfouk AA; Husein DZ; Ibrahim IM; Metwaly AM; Eissa IH
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144596
[TBL] [Abstract][Full Text] [Related]
17. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
18. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).
Shaheen MA; El-Emam AA; El-Gohary NS
Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080
[TBL] [Abstract][Full Text] [Related]
20. LASSBio-897 Reduces Lung Injury Induced by Silica Particles in Mice: Potential Interaction with the A
Carvalho VF; Ferreira TPT; de Arantes ACS; Noël F; Tesch R; Sant'Anna CMR; Barreiro EJL; Fraga CAM; Rodrigues E Silva PM; Martins MA
Front Pharmacol; 2017; 8():778. PubMed ID: 29163164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
